Variant report
Variant | esv3338823 |
---|---|
Chromosome Location | chr7:7581527-7585825 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:7582529..7585016-chr7:7587079..7589582,2 | K562 | blood: | |
2 | chr7:7463756..7464685-chr7:7580802..7582089,8 | MCF-7 | breast: | |
3 | chr7:7465052..7465954-chr7:7580703..7581616,2 | K562 | blood: | |
4 | chr7:7142758..7143661-chr7:7580812..7581638,2 | MCF-7 | breast: | |
5 | chr7:7463681..7464442-chr7:7580757..7581561,4 | K562 | blood: | |
6 | chr7:7463700..7464480-chr7:7580427..7581567,10 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MIOS-4 | chr7:7583810-7584201 | expReg_chr7_675_+ |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549148230 | chr7:7581551-7581552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369723169 | chr7:7581568-7581569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200508576 | chr7:7581572-7581573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543866213 | chr7:7581573-7581574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74397999 | chr7:7581584-7581585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs398003568 | chr7:7581585-7581586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571986802 | chr7:7581608-7581609 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs187558870 | chr7:7581627-7581628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10246969 | chr7:7581648-7581649 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs373600014 | chr7:7581661-7581662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541570768 | chr7:7581670-7581671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559794108 | chr7:7581672-7581673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536326176 | chr7:7581676-7581677 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372225804 | chr7:7581708-7581709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567375322 | chr7:7581709-7581710 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552320160 | chr7:7581711-7581712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554392331 | chr7:7581719-7581720 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572690896 | chr7:7581743-7581744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533698591 | chr7:7581746-7581747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374595151 | chr7:7581749-7581750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190917690 | chr7:7581750-7581751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144479287 | chr7:7581752-7581753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569321658 | chr7:7581816-7581817 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536629021 | chr7:7581839-7581840 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10247226 | chr7:7581841-7581842 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs142381072 | chr7:7581846-7581847 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534148980 | chr7:7581866-7581867 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559059494 | chr7:7581893-7581894 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150906178 | chr7:7581895-7581896 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140189700 | chr7:7581901-7581902 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184055735 | chr7:7581907-7581908 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544424562 | chr7:7581924-7581925 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs60663837 | chr7:7581944-7581945 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs374447561 | chr7:7581991-7581992 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541392018 | chr7:7581992-7581993 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs578211253 | chr7:7582014-7582015 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145389950 | chr7:7582019-7582020 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537898319 | chr7:7582022-7582023 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527334226 | chr7:7582032-7582033 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545690241 | chr7:7582035-7582036 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs10244335 | chr7:7582037-7582038 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs78161095 | chr7:7582040-7582041 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368694570 | chr7:7582045-7582046 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550130396 | chr7:7582076-7582077 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568349772 | chr7:7582179-7582180 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530130646 | chr7:7582192-7582193 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147664096 | chr7:7582201-7582202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187454050 | chr7:7582233-7582234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534256866 | chr7:7582242-7582243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142464404 | chr7:7582247-7582248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:7575800-7593000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
2 | chr7:7580600-7582600 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr7:7581200-7581600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr7:7581200-7581800 | Enhancers | Liver | Liver |
5 | chr7:7581200-7582600 | Enhancers | HepG2 | liver |
6 | chr7:7581400-7582200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
7 | chr7:7581400-7582400 | Enhancers | A549 | lung |
8 | chr7:7581800-7582200 | Flanking Active TSS | Liver | Liver |
9 | chr7:7581800-7595800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr7:7582200-7582600 | Enhancers | Liver | Liver |
11 | chr7:7582600-7588000 | Weak transcription | Liver | Liver |
12 | chr7:7582600-7589600 | Weak transcription | Muscle Satellite Cultured Cells | -- |